We provide you with 20 years of free, institutional-grade data for FENC stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of FENC. Explore the full financial landscape of FENC stock.
| Reported Date | CIK | Ticker | Type |
|---|
Fennec Pharmaceuticals Inc(NASDAQ:FENC) 
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced heari...
The information provided in this report about FENC stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.